Product image of Citrate D'yttrium (90y) Cis Bio International (Yttrium (90y) Citrate) supplied by GNH India

Citrate D'yttrium (90y) Cis Bio International

Active Ingredient:
Yttrium (90y) Citrate
Origin:
EU

Citrate D'yttrium (90y) Cis Bio International (Yttrium (90y) Citrate)

Yttrium (90y) Citrate by Cis Bio International is a radiopharmaceutical used for targeted therapeutic applications. Learn about its uses, effects, and precautions.

Manufacturer / TM Owner

Cis Bio International

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Yttrium (90y) Citrate is primarily used in medical procedures requiring localized radiation therapy. It is often administered for conditions that benefit from intraarticular use, targeting specific areas within joints. This radiopharmaceutical is designed to deliver precise radiation doses to affected tissues, supporting therapeutic interventions.

Side Effects

  • Yttrium (90y) Citrate works by emitting beta radiation, which can help in reducing abnormal cell activity in targeted areas. Patients may experience localized effects depending on the treatment area and individual response. Always follow medical guidance for optimal outcomes.

Precautions & Warnings

  • Handling Yttrium (90y) Citrate requires strict adherence to safety protocols due to its radioactive nature. It should only be administered by trained healthcare professionals in controlled environments. Proper shielding and protective measures are essential to minimize exposure risks.

Avoid Interactions

  • Yttrium (90y) Citrate may interact with other radioactive substances or medications used in radiation therapy. It is important to disclose all current treatments to your healthcare provider to avoid potential interactions. Always consult with a medical professional before combining treatments.

Frequently Asked Questions

Yttrium (90y) Citrate is used for targeted radiation therapy, often in procedures involving intraarticular use to treat specific conditions.

Yttrium (90y) Citrate is typically administered by healthcare professionals through intraarticular injection, directly into the joint area.

The primary effect of Yttrium (90y) Citrate is localized radiation, which can help reduce abnormal cell activity in targeted tissues.

Yes, strict safety protocols must be followed due to its radioactive nature, including proper shielding and protective measures.

Yttrium (90y) Citrate may interact with other radioactive substances or medications used in radiation therapy, so consult your healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Yttrium (90y) Citrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT